期刊文献+

亚砷酸对白血病K562/A02细胞的作用及机制 被引量:2

The Reversal of Arsenious Acid on Leukemia K562/A02 Cell Line and Its Mechanisms
下载PDF
导出
摘要 目的研究亚砷酸对白血病多药耐药细胞株K562/A02细胞的作用及对多药耐药基因1(mdr1)、P糖蛋白(P-gp)和血管内皮生长因子(VEGF)表达的影响,探讨亚砷酸逆转白血病多药耐药(MDR)的作用机制。方法将K562/A02细胞与不同浓度的亚砷酸(0、0.5、2.0、5.0μmol/L)共同孵育,分别在24、48、72h时,用Wrights染色法观察K562/A02细胞形态,流式细胞术(FCM)检测凋亡细胞,MTT法检测细胞增殖活性,RT-PCR法检测mdr1mRNA的表达,免疫组织化学法观察P-gp表达,并用ELISA法检测VEGF的浓度。结果随着亚砷酸作用浓度和时间的增加,K562/A02细胞的数目减少,并出现凋亡形态学改变,FCM显示随着作用浓度和时间的增加,细胞凋亡率逐渐上升;从作用48h组开始,mdr1mRNA及P-gp的表达出现显著降低(P<0.05),mdr1mRNA条带颜色较空白对照组明显变浅,mdrl/GAPDH灰度比值下降,此时,P-gp的灰度值上升,且随亚砷酸作用浓度和时间的增加,mdr1mRNA条带颜色进一步变浅,表达水平进一步下降;ELISA法检测表明从0.5μmol/L作用24h组开始,VEGF浓度即下降至405.02pg/mL(P<0.05),相同作用时间下以5.0μmol/L组较其它浓度组下调VEGF的作用最为显著。结论亚砷酸呈药物浓度-时间依赖性抑制K562/A02细胞增殖,诱导其凋亡,下调VEGF表达,有效抑制了mdrlmRNA的产生和P-gp的合成。 Objective To study the expression of multidurg resistance gene(mdr1) 、P-glycoprotein(P-gp) and vascular endothelial growth factor(VEGF) during apoptosis induced by Arsenious acid and explore the mechanism of reversal of apoptosis resistance by Arsenic trioxide in multidurg-resistant human leukemia K562/ A02 cell.Methods The K562/A02 cell was cultured in different concentration of Arsenious acid(0,0.5,2.0,5.0 μmol/L) and harvested in 24 h,48 h,72 h.The cell morphology was assayed by inverted microscope and Wright's stain.The cell apoptosis was examined by flow cytometer(FCM) .The cell proliferating activity was assessed by MTT assay.The expression of mdr1 mRNA was examined with reverse ranscription-polymerase chain raction(RT-PCR) .The P-gp was examined by immunohistochemistry assay.The VEGF levels were measured with enzyme-linked immunosorbent assay(ELISA) in cultural supernatants of K562/A02 cell.Results Arsenious acid could decrease the number of K562/A02 cell and increase the number of K562/A02 cell debris.The cell morphology showed typical morphological changes of apoptosis in K562/A02 cells with the apoptosis-induction of Arsenious acid,such as chromatin condensation,nuclear fragmentation and so on.It was showed apoptosis rate of K562/A02 cells was obviously increased in a dose-and time-dependent,respectively.Constitutive expression of mdr1 mRNA、P-gp and VEGF were detected by RT-PCR,immunohistochemistry assay and ELISA respectively.After treatmeat with Arsenious acid for 48h,the expression of mdr1 mRNA and P-gp showed significent decrease(P0.05) .K562/A02 cells exhibited decreased mdr1 mRNA and P-gp expression,grey scale ratio and grey scale numerus were respectively(P0.05) ,the expression of mdr1 mRNA and P-gp in K562/A02 cells decreased futher(P0.05) .After treated with the same time,when incubated with 5.0μmol/l Arsenious acid,the expression of VEGF was the least.Conclusion Arsenious acid can inhibit the proliferation of multidrug-resistant K562/A02 cell and induce the cell to undergo apoptosis in a dose-and time-dependent manner.Arsenious acid can inhibit the expression of VEGF,and inhibit mdr1 mRNA and P-gp expression in the cells.
出处 《中南医学科学杂志》 CAS 2011年第4期385-389,415,共6页 Medical Science Journal of Central South China
关键词 亚砷酸 白血病 细胞系 K562/A02 多药耐药 arsenious acid leukemia cell line K562/A02 multidrug resistance mechanism
  • 相关文献

参考文献8

二级参考文献22

  • 1周晋,孟然,杨宝峰.Comparing two arsenic trioxide administration methods in APL therapy[J].Chinese Medical Journal,2004(9):1411-1413. 被引量:18
  • 2周晋,孟然,隋新华,李丽敏,杜柏岩,杨宝峰.三氧化二砷持续缓慢静脉输注治疗高白细胞血症的疗效观察[J].中华内科杂志,2005,44(3):222-224. 被引量:5
  • 3张鹏,王树叶,胡龙虎,施福东,邱凤琴,洪珞珈,韩雪英,杨惠芬,宋颖昭,刘艳平,周晋,金镇敬.三氧化二砷注射液治疗72例急性早幼粒细胞白血病[J].中华血液学杂志,1996,17(2):58-60. 被引量:476
  • 4倪建华,陈国强,沈志祥,李秀松,刘海卫,黄燕婷,方智雯,陈赛娟,王振义,陈竺.静脉滴注三氧化二砷治疗急性早幼粒细胞白血病的药代动力学分析[J].中华血液学杂志,1997,18(5):250-253. 被引量:100
  • 5方福德 杨焕明 等.分子生物学前言技术[M].北京:北京医科大学中国协和医科大学联合出版社,1998.370-420.
  • 6Niu C,Yan H,Yu T,et al.Studies on treatment of acute promyelocytic leukemia with arsenic trioxide:remission indection,follow-up and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients.Blood,1999,94:3315-24.
  • 7Roberts TE,Sprague K,Schenkein D,et al.Hyperleukocytosis during induction therapy with arsenic trioxide for relapsed acute promyelocytic leukemia associated with central nervous system infarction[J].Blood,2000,96:4000-1.
  • 8Camosino I,Lataglatia R,Avvisati G,et al.Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia[J].Haematologica,2004,89:615-7.
  • 9Wing-Yan Au,Cyrus R,Kumana,et al.Oral arsenic trioxide in the treatment of relapsed acute promyelocyte leukemia[J].Blood,2003,102(1):407-8.
  • 10Grad JM,Bahlis NH,Reis I,et al.Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells[J].Blood,2001,98(3):805-13.

共引文献54

同被引文献24

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部